Literature DB >> 11531263

Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells.

T Yajima1, A Yagihashi, H Kameshima, D Kobayashi, K Hirata, N Watanabe.   

Abstract

Telomerase adds hexameric repeats of 5'-TTAGGG-3' termed telomeres to ends of chromosomal DNA. This enzyme has been implicated in cellular immortalization and cellular senescence. Recently, a number of relevant genes have been cloned, including these encoding three major components of human telomerase: human telomerase RNA component (hTR), human telomerase reverse transcriptase (hTERT), and telomerase-associated protein-1 (TEP1). Also important are genes encoding human telomeric-repeat binding factor protein (TRF) 1 and 2. To clarify mechanisms regulating telomerase activity, we studied telomerase activity, the telomeric restriction fragment (TRF) length and gene expression of these telomerase components and the telomeric-repeat binding factor proteins in sequential observation following X-irradiation of cultured pancreatic cancer cells. We previously reported that PANC-1 cells are better able to tolerate thermal stress, antineoplastic drugs, and exposure to tumour necrosis factor than MIAPaCa-2 cells. MIAPaCa-2 and PANC-1 cells were exposed to X-irradiation, their telomerase activity was increased at 2 days and then decreased gradually. Of the three telomerase components, only hTERT mRNA expression showed parallel changes. TRF length was stable just before and after X-irradiation. Among binding factor proteins, TRF1 mRNA showed reciprocal changes possibly directed toward maintaining a stable telomere length. In this study, our results demonstrate that not only hTERT but also TRF1 are important regulator of telomerase activity. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531263      PMCID: PMC2364122          DOI: 10.1054/bjoc.2001.1954

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  A human telomeric protein.

Authors:  L Chong; B van Steensel; D Broccoli; H Erdjument-Bromage; J Hanish; P Tempst; T de Lange
Journal:  Science       Date:  1995-12-08       Impact factor: 47.728

2.  Control of telomere length by the human telomeric protein TRF1.

Authors:  B van Steensel; T de Lange
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

3.  Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).

Authors:  N W Kim; F Wu
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

4.  Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells.

Authors:  N Watanabe; N Tsuji; Y Tsuji; H Sasaki; T Okamoto; S Akiyama; D Kobayashi; T Sato; N Yamauchi; Y Niitsu
Journal:  Pancreas       Date:  1996-11       Impact factor: 3.327

5.  Establishment of quantitative reverse transcription--polymerase chain reaction assays for human telomerase-associated genes.

Authors:  T Yajima; A Yagihashi; H Kameshima; D Furuya; D Kobayashi; K Hirata; N Watanabe
Journal:  Clin Chim Acta       Date:  2000-01-05       Impact factor: 3.786

6.  A mammalian telomerase-associated protein.

Authors:  L Harrington; T McPhail; V Mar; W Zhou; R Oulton; M B Bass; I Arruda; M O Robinson
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

7.  TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family.

Authors:  J Nakayama; M Saito; H Nakamura; A Matsuura; F Ishikawa
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

8.  Telomerase activity in human breast tumors.

Authors:  E Hiyama; L Gollahon; T Kataoka; K Kuroi; T Yokoyama; A F Gazdar; K Hiyama; M A Piatyszek; J W Shay
Journal:  J Natl Cancer Inst       Date:  1996-01-17       Impact factor: 13.506

9.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

10.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Authors:  C M Counter; A A Avilion; C E LeFeuvre; N G Stewart; C W Greider; C B Harley; S Bacchetti
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  6 in total

1.  Reduced expression of TRF1 is associated with tumor progression and poor prognosis in oral squamous cell carcinoma.

Authors:  Hui-Ching Chuang; Chang-Han Chen; Chao-Cheng Huang; Fu-Min Fang; Hsin-Ting Tsai; Chih-Yen Chien
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

2.  Clinical significance of telomere length and associated proteins in oral cancer.

Authors:  Rachana N Sainger; Shaila D Telang; Shilin N Shukla; Prabhudas S Patel
Journal:  Biomark Insights       Date:  2007-02-14

3.  Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.

Authors:  Chun Li; Ming-Yao Wu; Ying-Rui Liang; Xian-Ying Wu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 4.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

5.  Telomere profiling: toward glioblastoma personalized medicine.

Authors:  Sylvain Ferrandon; Paul Saultier; Julien Carras; Priscillia Battiston-Montagne; Gersende Alphonse; Michael Beuve; Céline Malleval; Jérôme Honnorat; Tania Slatter; Noelyn Hung; Janice Royds; Claire Rodriguez-Lafrasse; Delphine Poncet
Journal:  Mol Neurobiol       Date:  2012-10-12       Impact factor: 5.682

6.  PTOP and TRF1 help enhance the radio resistance in breast cancer cell.

Authors:  Zheng Li; Xiaoxi Yang; Nengxing Xia; Lei Yang; Haijun Yu; Fuxiang Zhou; Conghua X; Yunfeng Zhou
Journal:  Cancer Cell Int       Date:  2014-01-25       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.